The CMA Innovation Seminar & Supplier Expo, Annual Conference and Industry Awards will take place on 25 and 26 October in Sydney.
CMA CEO Carl Gibson said: “CMA has successfully led Australian delegations to China during the past 12 months, and these visits have underlined the growing importance of our friendship and the building of professional networks with our Chinese counterparts.
“The delegation aims to promote greater engagement between Chinese stakeholders, and members of the Australian complementary medicines industry. It is invaluable to support trade delegations from China to Australia, especially to attend events such as the innovation expo and annual conference.”
Gibson added that the demand for complementary medicines is growing rapidly in China, as an increasingly health-conscious population take a strong interest in their health and well-being.
"We are fortunate that Australia’s complementary medicines industry is backed by a regulatory regime that is regarded as one of the strongest in the world, and our products hold a global reputation for exceptional quality and safety standards.
“Trade with international markets is crucial for the long-term prosperity of the Australian complementary medicines industry, and China in particular is a very significant trading partner,” he said.